LFCR
Lifecore Biomedical Inc.
NASDAQ: LFCR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.07
+2.63% today
Updated 2026-04-30
Market cap
$190.38M
P/E ratio
—
P/S ratio
1.47x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$4 – $9
Volume
0.4M
Lifecore Biomedical Inc. (LFCR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-23.80%
Operating margin
8.18%
ROE
-76.40%
ROA
-3.04%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $231.95M | $8.65M | 17.26% | 3.89% | 3.73% |
| 2007 | $210.50M | $29.19M | 15.39% | 14.43% | 13.87% |
| 2008 | $238.53M | $13.54M | 16.03% | 6.36% | 5.68% |
| 2009 | $235.94M | $7.73M | 14.53% | 5.34% | 3.28% |
| 2010 | $238.22M | $3.98M | 14.17% | 4.91% | 1.67% |
| 2011 | $276.73M | $3.92M | 16.87% | 2.90% | 1.42% |
| 2012 | $317.55M | $12.70M | 16.42% | 4.59% | 4.00% |
| 2013 | $441.71M | $22.59M | 14.21% | 5.63% | 5.11% |
| 2014 | $476.81M | $19.14M | 13.12% | 4.23% | 4.02% |
| 2015 | $539.26M | $13.54M | 12.13% | 3.42% | 2.51% |
| 2016 | $541.10M | $-11.64M | 13.11% | -3.66% | -2.15% |
| 2017 | $532.26M | $10.59M | 15.63% | 2.91% | 1.99% |
| 2018 | $524.23M | $24.83M | 14.94% | 2.26% | 4.74% |
| 2019 | $557.56M | $2.12M | 14.53% | -1.44% | 0.38% |
| 2020 | $160.07M | $-38.19M | 24.61% | -16.17% | -23.86% |
| 2021 | $100.87M | $-32.29M | 38.60% | -8.75% | -32.01% |
| 2022 | $185.79M | $-97.43M | 27.11% | -1.94% | -52.44% |
| 2023 | $111.27M | $-116.72M | 35.11% | -10.60% | -104.89% |
| 2024 | $128.26M | $12.01M | 32.63% | -6.90% | 9.37% |
| 2025 | $128.87M | $-38.72M | 31.27% | -13.38% | -30.04% |